
Genomic test helps estimate risk of prostate cancer metastasis, death
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate…
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate…
An antidepressant in use for decades, repurposed to fight prostate cancer, shows promise in helping…
The featured clinical investigation article of the March 2017 issue of the Journal of Nuclear Medicine demonstrates…